Harvard Bioscience Inc
HBIO- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001123494
No open-market purchases or sales by Harvard Bioscience Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $10.3M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Harvard Bioscience Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- −4 vs. Q1 2022
- Shares held
- 29.7M
- −432.0K (−1.4%) vs. Q1 2022
- Total value
- $106.8M
- −$80.0M (−42.8%) vs. Q1 2022
- New holders
- 22
- 29 more added
- Sold out
- 26
- 30 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 37 | $10.3M |
| Q1 2026 | 37 | $7.73M |
| Q4 2025 | 64 | $11.7M |
| Q3 2025 | 61 | $7.29M |
| Q2 2025 | 69 | $8.39M |
| Q1 2025 | 92 | $14.5M |
| Q4 2024 | 96 | $65.5M |
| Q3 2024 | 95 | $84.2M |
| Q2 2024 | 100 | $90.7M |
| Q1 2024 | 90 | $137.8M |
| Q4 2023 | 93 | $176.4M |
| Q3 2023 | 94 | $141.6M |
| Q2 2023 | 100 | $178.2M |
| Q1 2023 | 66 | $127.2M |
| Q4 2022 | 68 | $83.3M |
| Q3 2022 | 79 | $74.0M |
| Q2 2022 | 91 | $106.8M |
| Q1 2022 | 98 | $187.3M |
| Q4 2021 | 103 | $211.4M |
| Q3 2021 | 99 | $191.7M |
| Q2 2021 | 99 | $232.3M |
| Q1 2021 | 87 | $144.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Harvard Bioscience Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Voya Investment Management LLC | 0 | $0 | 0.00% | −22,536−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −19,505−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −18,918−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −17,976−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −16,835−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −16,749−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −14,406−100.0% | Sold out |
| Lake Street Advisors Group, LLC | 0 | $0 | 0.00% | −12,479−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,590−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −11,386−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −10,536−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −6,378−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −6,198−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −3,851−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −3,333−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,766−100.0% | Sold out |
| Fortitude Advisory Group L.L.C. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |